BIOMAT Database Logo BIOMAT Database Logo

NF1 gene mutations in Japanese with neurofibromatosis 1 (NF1). 1995

N Hatta, and T Horiuchi, and I Watanabe, and Y Kobayashi, and Y Shirakata, and H Ohtsuka, and T Minami, and K Ueda, and T Kokoroishi, and S Fujita
First Department of Internal Medicine, School of Medicine, Ehime University, Japan.

Neurofibromatosis 1 (NF1) is an autosomal dominant disease characterized by abnormalities in multiple tissues derived from the neural crest. We analysed 50 unrelated Japanese patients for NF1 mutations by using polymerase chain reaction (PCR)-single strand conformation polymorphism (SSCP) analysis for exons 28 to 36. Here, we demonstrate a single base pair (bp) insertional mutations in exon 31 in one patient (5843insA/5844insA/5845insA/5846insA) and a single adenine to guanine transitional mutation 4 bp upstream from the 3' end of intron 31 in two unrelated cases. The insertional mutation in exon 31 was novel and resulted in premature termination of the transcript. The other intron 31 mutations resulted in 4 bp insertions of cDNA between exon 31 and exon 32 with premature termination of the transcript, indicating that those transitions of intron 31 caused aberrant splice acceptor sites upstream from the 5' end of exon 32. However, as the same mutation of intron 31 has been reported previously in two cases of unrelated Caucasians, the splice junction mutation of intron 31 is thought to be common among different ethnic groups.

UI MeSH Term Description Entries
D007438 Introns Sequences of DNA in the genes that are located between the EXONS. They are transcribed along with the exons but are removed from the primary gene transcript by RNA SPLICING to leave mature RNA. Some introns code for separate genes. Intervening Sequences,Sequences, Intervening,Intervening Sequence,Intron,Sequence, Intervening
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009456 Neurofibromatosis 1 An autosomal dominant inherited disorder (with a high frequency of spontaneous mutations) that features developmental changes in the nervous system, muscles, bones, and skin, most notably in tissue derived from the embryonic NEURAL CREST. Multiple hyperpigmented skin lesions and subcutaneous tumors are the hallmark of this disease. Peripheral and central nervous system neoplasms occur frequently, especially OPTIC NERVE GLIOMA and NEUROFIBROSARCOMA. NF1 is caused by mutations which inactivate the NF1 gene (GENES, NEUROFIBROMATOSIS 1) on chromosome 17q. The incidence of learning disabilities is also elevated in this condition. (From Adams et al., Principles of Neurology, 6th ed, pp1014-18) There is overlap of clinical features with NOONAN SYNDROME in a syndrome called neurofibromatosis-Noonan syndrome. Both the PTPN11 and NF1 gene products are involved in the SIGNAL TRANSDUCTION pathway of Ras (RAS PROTEINS). Peripheral Neurofibromatosis,Recklinghausen Disease of Nerve,von Recklinghausen Disease,Cafe-au-Lait Spots with Pulmonic Stenosis,Molluscum Fibrosum,NF1 (Neurofibromatosis 1),Neurofibromatosis I,Neurofibromatosis Type 1,Neurofibromatosis Type I,Neurofibromatosis, Peripheral Type,Neurofibromatosis, Peripheral, NF 1,Neurofibromatosis, Peripheral, NF1,Neurofibromatosis, Type 1,Neurofibromatosis, Type I,Pulmonic Stenosis with Cafe-au-Lait Spots,Recklinghausen Disease, Nerve,Recklinghausen's Disease of Nerve,Recklinghausens Disease of Nerve,Watson Syndrome,von Recklinghausen's Disease,Cafe au Lait Spots with Pulmonic Stenosis,Neurofibromatoses, Peripheral,Neurofibromatoses, Type I,Neurofibromatosis, Peripheral,Peripheral Neurofibromatoses,Pulmonic Stenosis with Cafe au Lait Spots,Syndrome, Watson,Type 1 Neurofibromatosis,Type 1, Neurofibromatosis,Type I Neurofibromatoses,Type I, Neurofibromatosis,von Recklinghausens Disease
D005091 Exons The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA. Mini-Exon,Exon,Mini Exon,Mini-Exons
D005260 Female Females
D006147 Guanine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000225 Adenine A purine base and a fundamental unit of ADENINE NUCLEOTIDES. Vitamin B 4,4, Vitamin B,B 4, Vitamin

Related Publications

N Hatta, and T Horiuchi, and I Watanabe, and Y Kobayashi, and Y Shirakata, and H Ohtsuka, and T Minami, and K Ueda, and T Kokoroishi, and S Fujita
Six novel mutations in the neurofibromatosis type 1 (NF1) gene.
January 1997, Human mutation,
N Hatta, and T Horiuchi, and I Watanabe, and Y Kobayashi, and Y Shirakata, and H Ohtsuka, and T Minami, and K Ueda, and T Kokoroishi, and S Fujita
Novel human pathological mutations. Gene symbol: NF1. Disease: neurofibromatosis 1.
June 2007, Human genetics,
N Hatta, and T Horiuchi, and I Watanabe, and Y Kobayashi, and Y Shirakata, and H Ohtsuka, and T Minami, and K Ueda, and T Kokoroishi, and S Fujita
Novel human pathological mutations. Gene symbol: NF1. Disease: Neurofibromatosis 1.
January 2010, Human genetics,
N Hatta, and T Horiuchi, and I Watanabe, and Y Kobayashi, and Y Shirakata, and H Ohtsuka, and T Minami, and K Ueda, and T Kokoroishi, and S Fujita
Novel mutations in the NF1 gene in Czech patients with neurofibromatosis type 1.
January 2007, Journal of molecular neuroscience : MN,
N Hatta, and T Horiuchi, and I Watanabe, and Y Kobayashi, and Y Shirakata, and H Ohtsuka, and T Minami, and K Ueda, and T Kokoroishi, and S Fujita
Novel and recurrent mutations in the neurofibromatosis type 1 (NF1) gene.
January 1997, Human mutation,
N Hatta, and T Horiuchi, and I Watanabe, and Y Kobayashi, and Y Shirakata, and H Ohtsuka, and T Minami, and K Ueda, and T Kokoroishi, and S Fujita
Characterisation of germline mutations in the neurofibromatosis type 1 (NF1) gene.
September 1995, Journal of medical genetics,
N Hatta, and T Horiuchi, and I Watanabe, and Y Kobayashi, and Y Shirakata, and H Ohtsuka, and T Minami, and K Ueda, and T Kokoroishi, and S Fujita
NF1 mutations in neurofibromatosis 1 patients with plexiform neurofibromas.
March 2002, Human mutation,
N Hatta, and T Horiuchi, and I Watanabe, and Y Kobayashi, and Y Shirakata, and H Ohtsuka, and T Minami, and K Ueda, and T Kokoroishi, and S Fujita
NF1 gene and neurofibromatosis 1.
January 2000, American journal of epidemiology,
N Hatta, and T Horiuchi, and I Watanabe, and Y Kobayashi, and Y Shirakata, and H Ohtsuka, and T Minami, and K Ueda, and T Kokoroishi, and S Fujita
[Analysis of NF1 gene mutations in two sporadic patients with neurofibromatosis type 1].
August 2018, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics,
N Hatta, and T Horiuchi, and I Watanabe, and Y Kobayashi, and Y Shirakata, and H Ohtsuka, and T Minami, and K Ueda, and T Kokoroishi, and S Fujita
Neurofibromatosis type 1 (NF1): Identification of eight unreported mutations in NF1 gene in Italian patients [corrected].
August 2003, Human mutation,
Copied contents to your clipboard!